Characterization of Hemorrhagic and Ischemic Stroke in a Diverse Cohort of COVID-19 Patients.
Alexander D RamosFeliks KoyfmanKory ByrnsAlan WuJay YasenLauren ElredaSrikanth BodduSammy PishanidarBaxter AllenRupa G JuthaniPublished in: The Neurohospitalist (2021)
COVID status, independent of severity, was significantly associated with higher mortality in stroke patients. COVID+ stroke patients were younger and less likely to be on antiplatelets, with higher rates of thrombocytopenia, suggesting a possible role for antiplatelet use in this population.